Biomarkers in Brain Disease
11 – 20 of 63
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Skeletal muscle regeneration is altered in the R6/2 mouse model of Huntington’s disease
2022) p.1-23(
- Working paper/Preprint › Preprint in preprint archive
- 2021
-
Mark
Human α-synuclein overexpression in a mouse model of Parkinson’s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation
(
- Contribution to journal › Article
-
Mark
Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
(
- Contribution to journal › Article
- 2020
-
Mark
Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
(
- Contribution to journal › Article
-
Mark
A hypothesis for insulin resistance in primary human adipocytes involving MRTF-A and suppression of PPARγ
(
- Contribution to journal › Article
- 2019
-
Mark
Energy metabolism as a target for new treatment strategies in Huntington’s disease
(
- Thesis › Doctoral thesis (monograph)
-
Mark
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
- 2018
-
Mark
Brain pericyte activation occurs early in Huntington's disease
(
- Contribution to journal › Article
-
Mark
A critical evaluation of wet biomarkers for huntington's disease : Current status and ways forward
(
- Contribution to journal › Scientific review
-
Mark
Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington's Disease
(
- Contribution to journal › Article